Enteric Empty Capsules Market Growth to US$ 4.6 Bn by 2032, says Persistence Market Research

The global enteric empty capsules market has emerged as a key segment within the pharmaceutical and nutraceutical industries, primarily driven by the rising demand for targeted drug delivery systems and advancements in capsule manufacturing technologies. Market size projections suggest that the enteric empty capsules sector will reach a valuation of US$ 3.1 billion by 2025 and is estimated to grow to US$ 4.6 billion by 2032, reflecting a steady compound annual growth rate (CAGR) of 6.0% from 2025 to 2032.

Enteric capsules were developed to ensure the safe delivery of sensitive medications, particularly those that are degraded by gastric acid or irritate the stomach lining. Their role in protecting drugs from stomach acids and ensuring effective absorption in the intestines has made them indispensable in the pharmaceutical and nutraceutical markets.

Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/34728

Key Industry Highlights

The enteric empty capsules market has witnessed significant growth in recent years, driven by the increasing demand for innovative pharmaceutical products. Pharmaceutical companies are investing heavily in research and development (R&D) to introduce new drug delivery technologies, further propelling the growth of the market. Technological advancements in capsule manufacturing, such as the development of personalized capsule machines and precision-engineered delivery systems, are further enhancing the market's prospects.

The nutraceutical industry is also playing a key role in the market's expansion, with the nutraceutical manufacturers segment expected to hold a market share of 32.79% by 2025. North America is expected to maintain a dominant position in the global market by 2025, driven by a growing focus on effective drug delivery systems and rising gastrointestinal (GI) disorders.

Market Dynamics
Drivers

The rising prevalence of gastrointestinal disorders, particularly among the aging population, is one of the major drivers of the enteric empty capsules market. Conditions like acid reflux, irritable bowel syndrome (IBS), and stomach ulcers are becoming increasingly common, significantly contributing to the demand for enteric capsules. According to a study by the Rome Foundation, over 40% of the global population suffers from functional gastrointestinal disorders (FGIDs), which underscores the need for targeted drug delivery solutions.

Enteric capsules are crucial in treating such conditions as they help prevent the degradation of sensitive drugs by stomach acid, allowing for better absorption in the intestines. Furthermore, the increasing awareness of the benefits of enteric capsules in controlled-release formulations and their ability to improve the bioavailability of drugs is accelerating their adoption by pharmaceutical companies.

Restraints

Despite their benefits, the enteric empty capsules market faces challenges related to the growing preference for plant-based and vegetarian drug alternatives. Gelatin-based capsules, which are derived from animal sources, are still the most commonly used in the production of enteric capsules. However, many consumers, patients, and healthcare professionals are increasingly avoiding animal-based products due to dietary, ethical, and religious reasons. This shift toward plant-based capsules poses adoption challenges for the enteric capsule market.

Moreover, ensuring a steady supply of raw materials for gelatin-based capsules and maintaining high-quality standards is becoming increasingly expensive, which could hinder market growth. Companies must address these supply-side challenges to ensure sustainability and meet evolving consumer preferences.

Opportunities

Technological advancements in capsule manufacturing represent a major opportunity for the market. Innovations such as precision-engineered capsule delivery systems and personalized capsule machines are enabling companies to expand their product offerings. For instance, ACG, a multinational pharmaceutical company, launched the first-ever personalized capsule machine in 2025, designed for precision-engineered delivery of supplement capsules tailored to individual needs. These advancements enhance the capabilities of enteric capsules, allowing for better therapeutic efficacy and improved patient compliance.

Additionally, growing consumer awareness about the benefits of new pharmaceutical products and the increasing use of nutraceuticals are expected to fuel demand for enteric capsules, particularly for probiotic and herbal supplements. These trends offer significant growth potential for market players in the coming years.

Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/enteric-empty-capsules-market.asp

Category-Wise Analysis

Product Insights

The enteric empty capsules market is segmented by product type into gelatin capsules, hydroxypropyl methylcellulose (HPMC) capsules, and vegetable capsules. Gelatin-based capsules dominate the market, accounting for a substantial 61.40% of the market share in 2024. This is primarily due to the widespread use of gelatin to coat capsules and protect sensitive drugs from stomach acids. Gelatin capsules are particularly valued for their strong targeted drug delivery capabilities, which are crucial for precision therapeutics and controlled-release formulations.

The HPMC and vegetable capsules segments are also growing in popularity, especially among consumers seeking plant-based alternatives to gelatin capsules. HPMC capsules, in particular, are gaining traction in the pharmaceutical and nutraceutical industries due to their ability to provide acid-resistant properties without the use of animal-derived ingredients.

End-User Insights

The end-user segment of the enteric empty capsules market includes the pharmaceutical industry, nutraceutical industry, and other sectors. The pharmaceutical industry holds the largest share of the market, accounting for 68.70% in 2024. Pharmaceutical companies are heavily invested in R&D and have the regulatory expertise to drive the demand for enteric capsules, particularly for the treatment of chronic conditions. The growing need for targeted drug delivery systems, combined with increasing awareness of the benefits of enteric capsules in improving bioavailability and reducing side effects, positions pharmaceutical companies as the primary users of enteric empty capsules.

While the nutraceutical industry is increasingly adopting enteric capsules for probiotics and herbal supplements, pharmaceutical companies continue to dominate due to their leadership in innovation and strong compliance with regulatory standards.

Regional Insights
North America

North America is expected to account for 42.4% of the global enteric empty capsules market share in 2025. This dominance is driven by the region's focus on targeted drug delivery systems and the high incidence of gastrointestinal disorders. A study by the University of North Carolina reported that over 40 million people in the U.S. suffer from digestive diseases, leading to millions of clinical visits annually. This growing prevalence is prompting pharmaceutical companies in the region to focus on developing enteric capsules for the effective delivery of acid-sensitive medications.

Europe

Europe's enteric empty capsules market is also expanding rapidly, supported by a strong healthcare infrastructure and a growing emphasis on pharmaceutical innovation. European companies are investing in plant-based and gelatin-free capsules to align with consumer preferences for clean-label and vegetarian products. Additionally, regulatory bodies like the European Medicines Agency (EMA) are playing a significant role in encouraging the development of advanced capsule technologies.

Asia-Pacific

The Asia-Pacific region is emerging as a high-growth market for enteric empty capsules, with increasing healthcare awareness, a robust pharmaceutical production sector, and rising demand for nutraceuticals. Countries like China and India are witnessing a surge in gastrointestinal disorders, which is driving the demand for enteric capsules. The region's strong manufacturing capabilities and cost-effective production models are attracting global capsule manufacturers, further contributing to market growth.

Competitive Landscape

The global enteric empty capsules market is highly competitive, with several key players vying for market share. Companies are adopting a variety of strategies, including mergers and acquisitions, strategic partnerships, new product launches, and investments in R&D.

Key Industry Developments

In May 2024, a study published in Molecular Pharmaceutics highlighted the development of enteric-coated capsules designed for targeted drug release in the distal ileum, an area rich in Peyer's patches and critical for immune system activation.

In November 2022, Lonza Group introduced Enprotec Capsules, designed to deliver acid-sensitive active pharmaceutical ingredients (APIs) directly to the intestine, eliminating the need for additional coating or sealing processes.

In May 2021, Evonik launched EUDRACAP, a commercial-scale functional capsule platform tailored for rapid drug development, particularly for the delivery of sensitive biological therapeutics.

Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/34728

Key Players in the Market

Lonza
Roquette Frères
SUHEUNG
Farmacápsulas
Nectar Lifesciences Ltd.
Zhejiang Huili Capsules Co., Ltd.
Shaoxing Zhongya Capsule Co., Ltd.
Chemcaps Limited
Fortcaps

Market Segmentation

By Product

Gelatin Capsules
Hydroxypropyl Methylcellulose (HPMC) Capsules
Vegetable Capsules
By End-user

Pharmaceutical Manufacturers
Nutraceutical Manufacturers
Others

By Application

Antacid and Antiflatulent Preparations
Antibiotic and Antibacterial Drugs
Others

By Region

North America
Europe
Asia Pacific
Latin America
The Middle East and Africa

Recent Developments

Technological advancements in capsule formulation are revolutionizing the market, with companies like ACG and Evonik leading the way in creating precision-engineered delivery systems.

Rising consumer demand for plant-based and vegetarian alternatives is driving innovation in the production of gelatin-free capsules.

Future Outlook

The future of the enteric empty capsules market looks promising, driven by technological advancements, growing consumer demand for targeted drug delivery solutions, and the rising prevalence of gastrointestinal disorders. As pharmaceutical and nutraceutical companies continue to innovate, the market is expected to experience sustained growth, with North America, Europe, and Asia-Pacific emerging as key growth regions.

Read More Related Reports:

Psychedelic Api Market https://www.persistencemarketresearch.com/market-research/psychedelic-api-market.asp
Patient Controlled Analgesic Pumps Market https://www.persistencemarketresearch.com/market-research/patient-controlled-analgesic-pumps-market.asp
Adhesive Bandages Market https://www.persistencemarketresearch.com/market-research/adhesive-bandages-market.asp
Melatonin Api Market https://www.persistencemarketresearch.com/market-research/melatonin-api-market.asp
Tryptamines Api Market https://www.persistencemarketresearch.com/market-research/tryptamines-api-market.asp
Alcohol Tests Market https://www.persistencemarketresearch.com/market-research/alcohol-tests-market.asp

Contact Us:

Persistence Market Research
Second Floor, 150 Fleet Street, London, EC4A 2DQ, United Kingdom
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.